175 related articles for article (PubMed ID: 36912931)
1. CiTSA: a comprehensive platform provides experimentally supported signatures of cancer immunotherapy and analysis tools based on bulk and scRNA-seq data.
Li F; Dong K; Zhang C; Wang J; Tang Y; Xue K; Zheng X; Song K; Zhang X; Li M; Zhao R; Zhong X; Xu Y; Zhang Y; Li X
Cancer Immunol Immunother; 2023 Jul; 72(7):2319-2330. PubMed ID: 36912931
[TBL] [Abstract][Full Text] [Related]
2. Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data.
Gao Y; Shang S; Guo S; Li X; Zhou H; Liu H; Sun Y; Wang J; Wang P; Zhi H; Li X; Ning S; Zhang Y
Nucleic Acids Res; 2021 Jan; 49(D1):D1251-D1258. PubMed ID: 33219685
[TBL] [Abstract][Full Text] [Related]
3. CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data.
Hu C; Li T; Xu Y; Zhang X; Li F; Bai J; Chen J; Jiang W; Yang K; Ou Q; Li X; Wang P; Zhang Y
Nucleic Acids Res; 2023 Jan; 51(D1):D870-D876. PubMed ID: 36300619
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive overview of oncogenic pathways in human cancer.
Li F; Wu T; Xu Y; Dong Q; Xiao J; Xu Y; Li Q; Zhang C; Gao J; Liu L; Hu X; Huang J; Li X; Zhang Y
Brief Bioinform; 2020 May; 21(3):957-969. PubMed ID: 31155677
[TBL] [Abstract][Full Text] [Related]
6. Survival Genie, a web platform for survival analysis across pediatric and adult cancers.
Dwivedi B; Mumme H; Satpathy S; Bhasin SS; Bhasin M
Sci Rep; 2022 Feb; 12(1):3069. PubMed ID: 35197510
[TBL] [Abstract][Full Text] [Related]
7. Innovative prognostic modeling in ESCC: leveraging scRNA-seq and bulk-RNA for dendritic cell heterogeneity analysis.
Shi M; Zhang H; Ma L; Wang X; Sun D; Feng Z
Front Immunol; 2024; 15():1352454. PubMed ID: 38515748
[TBL] [Abstract][Full Text] [Related]
8. LnCeCell: a comprehensive database of predicted lncRNA-associated ceRNA networks at single-cell resolution.
Wang P; Guo Q; Hao Y; Liu Q; Gao Y; Zhi H; Li X; Shang S; Guo S; Zhang Y; Ning S; Li X
Nucleic Acids Res; 2021 Jan; 49(D1):D125-D133. PubMed ID: 33219686
[TBL] [Abstract][Full Text] [Related]
9. AgingBank: a manually curated knowledgebase and high-throughput analysis platform that provides experimentally supported multi-omics data relevant to aging in multiple species.
Gao Y; Shang S; Guo S; Wang X; Zhou H; Sun Y; Gan J; Zhang Y; Li X; Ning S; Zhang Y
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36239391
[TBL] [Abstract][Full Text] [Related]
10. TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment.
Sun D; Wang J; Han Y; Dong X; Ge J; Zheng R; Shi X; Wang B; Li Z; Ren P; Sun L; Yan Y; Zhang P; Zhang F; Li T; Wang C
Nucleic Acids Res; 2021 Jan; 49(D1):D1420-D1430. PubMed ID: 33179754
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights.
Ma Y; Du J; Chen M; Gao N; Wang S; Mi Z; Wei X; Zhao J
Front Immunol; 2023; 14():1219652. PubMed ID: 37457713
[TBL] [Abstract][Full Text] [Related]
12. CTISL: a dynamic stacking multi-class classification approach for identifying cell types from single-cell RNA-seq data.
Wang X; Chai Z; Li S; Liu Y; Li C; Jiang Y; Liu Q
Bioinformatics; 2024 Feb; 40(2):. PubMed ID: 38317054
[TBL] [Abstract][Full Text] [Related]
13. Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication.
Chen D; Liu P; Lu X; Li J; Qi D; Zang L; Lin J; Liu Y; Zhai S; Fu D; Weng Y; Li H; Shen B
J Exp Clin Cancer Res; 2024 Apr; 43(1):125. PubMed ID: 38664705
[TBL] [Abstract][Full Text] [Related]
14. TransLnc: a comprehensive resource for translatable lncRNAs extends immunopeptidome.
Lv D; Chang Z; Cai Y; Li J; Wang L; Jiang Q; Xu K; Ding N; Li X; Xu J; Li Y
Nucleic Acids Res; 2022 Jan; 50(D1):D413-D420. PubMed ID: 34570220
[TBL] [Abstract][Full Text] [Related]
15. LncTarD: a manually-curated database of experimentally-supported functional lncRNA-target regulations in human diseases.
Zhao H; Shi J; Zhang Y; Xie A; Yu L; Zhang C; Lei J; Xu H; Leng Z; Li T; Huang W; Lin S; Wang L; Xiao Y; Li X
Nucleic Acids Res; 2020 Jan; 48(D1):D118-D126. PubMed ID: 31713618
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response.
Zhang Z; Wang ZX; Chen YX; Wu HX; Yin L; Zhao Q; Luo HY; Zeng ZL; Qiu MZ; Xu RH
Genome Med; 2022 Apr; 14(1):45. PubMed ID: 35488273
[TBL] [Abstract][Full Text] [Related]
17. ImmCluster: an ensemble resource for immunology cell type clustering and annotations in normal and cancerous tissues.
Jiang T; Zhou W; Sheng Q; Yu J; Xie Y; Ding N; Zhang Y; Xu J; Li Y
Nucleic Acids Res; 2023 Jan; 51(D1):D1325-D1332. PubMed ID: 36271790
[TBL] [Abstract][Full Text] [Related]
18. HArmonized single-cell RNA-seq Cell type Assisted Deconvolution (HASCAD).
Chiu YJ; Ni CE; Huang YH
BMC Med Genomics; 2023 Oct; 16(Suppl 2):272. PubMed ID: 37907883
[TBL] [Abstract][Full Text] [Related]
19. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment.
Han Y; Wang Y; Dong X; Sun D; Liu Z; Yue J; Wang H; Li T; Wang C
Nucleic Acids Res; 2023 Jan; 51(D1):D1425-D1431. PubMed ID: 36321662
[TBL] [Abstract][Full Text] [Related]
20. LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA-target regulations in human diseases.
Zhao H; Yin X; Xu H; Liu K; Liu W; Wang L; Zhang C; Bo L; Lan X; Lin S; Feng K; Ning S; Zhang Y; Wang L
Nucleic Acids Res; 2023 Jan; 51(D1):D199-D207. PubMed ID: 36321659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
